Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0606920130210030222
Biomolecules & Therapeutics
2013 Volume.21 No. 3 p.222 ~ p.228
Valproic Acid Regulates ¥á-Synuclein Expression through JNK Pathway in Rat Primary Astrocytes
Kim Jung-Nam

Kim Min-Kyeong
Cho Kyu-Suk
Choi Chang-Soon
Park Seung-Hwa
Yang Sung-IL
Joo So-Hyun
Park Jin-Hee
Bahn Geon-Ho
Shin Chan-Young
Lee He-Jin
Han Seol-Heui
Kwon Kyoung-Ja
Abstract
Although the role of ¥á-synuclein aggregation on Parkinson¡¯s disease is relatively well known, the physiological role and the regulatory mechanism governing the expression of ¥á-synuclein are unclear yet. We recently reported that ¥á-synuclein is expressed and secreted from cultured astrocytes. In this study, we investigated the effect of valproic acid (VPA), which has been suggested to provide neuroprotection by increasing ¥á-synuclein in neuron, on ¥á-synuclein expression in rat primary astrocytes. VPA concentrationdependently increased the protein expression level of ¥á-synuclein in cultured rat primary astrocytes with concomitant increase in mRNA expression level. Likewise, the level of secreted ¥á-synuclein was also increased by VPA. VPA increased the phosphorylation of Erk1/2 and JNK and pretreatment of a JNK inhibitor SP600125 prevented the VPA-induced increase in ¥á-synuclein. Whether the increased ¥á-synuclein in astrocytes is involved in the reported neuroprotective effects of VPA awaits further investigation.
KEYWORD
¥á-synuclein, Valproic acid, Stability, JNK, Neuroprotection, Acetylation
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed